Journals / Turkish Journal of Medical Sciences / 2019 / Cilt: 49 - Sayı: 1

8-Hydroxy-2’-deoxyguanosine as a biomarker of oxidative stress in acute exacerbation of chronic obstructive pulmonary disease

Pages
93–100
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Additionally,further analysis revealed that 8-OHdG was negatively correlated with FEV1, FEV1% predicted, and FEV1/FVC and positively correlatedwith C-reactive protein, procalcitonin, and neutrophil CD64.Conclusion: 8-OHdG is associated with spirometric severity, symptomatic severity, exacerbation risk, and inflammatory biomarkers inAECOPD patients, suggesting it as a promising biomarker for reflecting disease severity and guiding the choice of optimal therapeuticdecision.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: 8-Hydroxy-2’-deoxyguanosine (8-OHdG) is a biomarker of oxidative stress and has been implicated in manydiseases.
📊
Key Findings & Data:The aim of this study was to investigate the clinical value of plasma 8-OHdG level in patients with acute exacerbation of chronicobstructive pulmonary disease (AECOPD).Materials and methods: A total of 154 subjects were enrolled in this study, including 20 healthy volunteers, 24 COPD patients in thestable phase, and 110 AECOPD patients.
💡
Conclusion & Impact:Additionally,further analysis revealed that 8-OHdG was negatively correlated with FEV1, FEV1% predicted, and FEV1/FVC and positively correlatedwith C-reactive protein, procalcitonin, and neutrophil CD64.Conclusion: 8-OHdG is associated with spirometric severity, symptomatic severity, exacerbation risk, and inflammatory biomarkers inAECOPD patients, suggesting it as a promising biomarker for reflecting disease severity and guiding the choice of optimal therapeuticdecision.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: 8-Hydroxy-2’-deoxyguanosine (8-OHdG) is a biomarker of oxidative stress and has been implicated in manydiseases. The aim of this study was to investigate the clinical value of plasma 8-OHdG level in patients with acute exacerbation of chronicobstructive pulmonary disease (AECOPD).Materials and methods: A total of 154 subjects were enrolled in this study, including 20 healthy volunteers, 24 COPD patients in thestable phase, and 110 AECOPD patients. Peripheral blood samples, demographic information, and clinical characteristics were collectedfrom all subjects at the time of being recruited into the study. Plasma 8-OHdG level was detected by enzyme-linked immunosorbentassay.Results: 8-OHdG was increased in patients with AECOPD compared to healthy subjects and patients with stable COPD, especially insmokers. It also increased with the GOLD stage, mMRC grade, CAT score, and group level of combined COPD assessment. Additionally,further analysis revealed that 8-OHdG was negatively correlated with FEV1, FEV1% predicted, and FEV1/FVC and positively correlatedwith C-reactive protein, procalcitonin, and neutrophil CD64.Conclusion: 8-OHdG is associated with spirometric severity, symptomatic severity, exacerbation risk, and inflammatory biomarkers inAECOPD patients, suggesting it as a promising biomarker for reflecting disease severity and guiding the choice of optimal therapeuticdecision.

🔖

Cite This Article

FENG, G., DENG, K., GAO, T., CHEN, S., WENG, X., ZHANG, Y., YAO, J., LIU, X., ZHANG, Y. (2022). 8-Hydroxy-2’-deoxyguanosine as a biomarker of oxidative stress in acute exacerbation of chronic obstructive pulmonary disease. Turkish Journal of Medical Sciences, Cilt: 49 - Sayı: 1, 93–100. https://ajindex.com/articles/610176

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370: 765-773
  2. Celli BR, MacNee W, Force AET. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ ERS position paper. Eur Respir J 2004; 23: 932-946
  3. Budweiser S, Harlacher M, Pfeifer M, Jorres RA. Comorbidities and hyperinflation are independent risk factors of all-cause mortality in very severe COPD. COPD 2014; 11: 388- 400
  4. Miller MR. Multicomponent indices to predict survival in COPD. Eur Respir J 2014; 43: 1206
  5. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347- 365
  6. Almagro P, Soriano JB, Cabrera FJ, Boixeda R, AlonsoOrtiz MB, Barreiro B, Diez-Manglano J, Murio C, Heredia JL; Working Group on COPD, Spanish Society of Internal Medicine. Short- and medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index. Chest 2014; 145: 972-980
  7. Casadevall C, Coronell C, Ramirez-Sarmiento AL, MartinezLlorens J, Barreiro E, Orozco-Levi M, Gea J. Upregulation of pro-inflammatory cytokines in the intercostal muscles of COPD patients. Eur Respir J 2007; 30: 701-707
  8. Garcia-Rio F, Miravitlles M, Soriano JB, Munoz L, DuranTauleria E, Sanchez G, Sobradillo V, Ancochea J; EPI-SCAN Steering Committee. Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir Res 2010; 11: 63
  9. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, Johnston SL. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 2006; 173: 1114- 1121
  10. Papakonstantinou E, Roth M, Klagas I, Karakiulakis G, Tamm M, Stolz D. COPD exacerbations are associated with proinflammatory degradation of hyaluronic acid. Chest 2015; 148: 1497-1507
  11. Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am J Respir Crit Care Med 1997; 156: 341-357
  12. Rahman I, Adcock IM. Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J 2006; 28: 219-242
  13. Mavelli I, Rigo A, Federico R, Ciriolo MR, Rotilio G. Superoxide dismutase, glutathione peroxidase and catalase in develo